Treatment if hibernating myocardium and diabetic cordiomyopathy with a GLP-1 peptide
Details for Australian Patent Application No. 2004229049 (hide)
International Classifications
Event Publications
25 November 2004 Complete Application Filed
9 December 2004 Application Open to Public Inspection
Published as AU-A-2004229049
23 December 2004 Amendment Made
The nature of the amendment is: Amend the invention title to read Treatment Of Hibernating Myocardium Or Pulmonary Congestion.
1 November 2007 Application Accepted
Published as AU-A-2004229049
28 February 2008 Standard Patent Sealed
31 July 2008 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 04 Jul 2008. Address for service in Australia - Davies Collison Cave Level 15 1 Nicholson Street Melbourne VIC 3000
11 December 2008 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 04 Jul 2008
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004229050-VIPCom2VIPCom Communications
2004229048-Method and apparatus for multi-sensory speech enhancement
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser